Advertisement

The Search for Peptides with Specific Antibradykinin Activity

  • John Morrow Stewart
  • D. W. Woolley

Abstract

Bradykinin and other related kinins present to the pharmacologist a complex and sometimes confusing spectrum of activities. The biochemical mechanisms by means of which these effects are produced are as yet unknown. The use of specific antimetabolites has in the past provided much insight into the mode of action of a number of biologically important substances. Work in this laboratory has been directed toward the goal of the design and synthesis of specific antimetabolites of bradykinin in the hope that these antimetabolites might be used to clarify some of the present uncertainties about the mode of action of that hormone. In addition, such specific antimetabolites might be useful in those clinical conditions that are characterized by the production of excessive amounts of bradykinin.

Keywords

Correct Amino Acid Abnormal Amino Acid Bradykinin Activity Bradykinin Analog Italicize Residue 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bodanszky, M., M. A. Ondetti, J. T. Sheehan, and S. Lande: Synthetic peptides related to bradykinin. Ann. N.Y. Acad. Sci. 104, 24 (1963).CrossRefGoogle Scholar
  2. Flouret, G., and V. du Vigneaud: The Synthesis of D-oxytocin, the enantiomer of the posterior pituitary hormone, oxytocin. J. Amer, ehem. Soc. 87, 3775 (1965).CrossRefGoogle Scholar
  3. Hano, K., M. Koida, K. Kubo, and H. Yajima: Evaluation of the physiological properties of D-histidyl-D-phenylalanyl-D- arginyl-D-tryptophyl-glycine in frog melanocytes. Biochim. biophys. Acta 90, 201 (1964).Google Scholar
  4. Law, H. D., and V. du Vigneaud: Synthesis of 2-p-methoxy- phenylalanine oxytocin and some observations on its pharma-cological behavior. J. Amer, ehem. Soc. 82, 4579 (1960).CrossRefGoogle Scholar
  5. Merrifield, R. B.: Competitive inhibition of a strepogenin-active peptide by related peptides. J. biol. Chem. 232, 43 (1958).Google Scholar
  6. Merrifield, R. B.: Solid-phase peptide synthesis. III. An improved synthesis of bradykinin. Biochemistry 3, 1385 (1964).CrossRefGoogle Scholar
  7. Merrifield, R. B., and J. M. Stewart: Automated peptide synthesis. Nature (Lond.) 207, 522 (1965).CrossRefGoogle Scholar
  8. Nicolaides, E. D. A. McCarthy, andD. E. Potter: Bradykinin: Configuration of the arginine moieties and biological activity. Biochemistry 4, 190, 1965.Google Scholar
  9. Schroder, E., and R. Hempel: Bradykinin, kallidin, and their synthetic analogues. Experientia (Basel) 20, 529 (1964).CrossRefGoogle Scholar
  10. Sheppard, R. C.: Amino acids and peptides, in Annual Reports on the Progress of Chemistry, 60, 460. London: the Chemical Society (1964).Google Scholar
  11. Smyth, D. G.: Molecular mechanism of oxytocin action. J. biol. Chem., in press (1966).Google Scholar
  12. Stewart, J. M., and D. W.Woolley: Threonine analogs of bradykinin designed as antimetabolites. Biochemistry 3, 700 (1964).CrossRefGoogle Scholar
  13. Stewart, J. M., and D. W. Woolley: All-D-bradykinin and the problem of peptide antimetabolites. Nature (Lond.) 206, 619 (1965a).CrossRefGoogle Scholar
  14. Stewart, J. M., and D. W. Woolley: Importance of the carboxyl end of bradykinin and other peptides. Nature (Lond.) 207, 1160 (1965b).CrossRefGoogle Scholar
  15. Vogler, K., P. Lanz, andW. Lergier: Synthesis of the bradykinin analog with reversed amino acid sequence. Helv. chim. Acta 45, 561 (1962).Google Scholar

Copyright information

© Springer-Verlag New York Inc. 1966

Authors and Affiliations

  • John Morrow Stewart
    • 1
  • D. W. Woolley
    • 1
  1. 1.The Rockefeller UniversityNew YorkUSA

Personalised recommendations